window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 5, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

pharmaceutical manufacturing

  • Biotech & Pharma Business,Drug Delivery & Formulation,Drug Discovery & Development

    Symeres expands spray drying capacity at New Jersey site to support poorly soluble small molecules

    Symeres has expanded spray drying capabilities at its Cranbury site [...]

    June 10, 2026
  • Clinical & Regulatory,Manufacturing & Supply Chain

    Reacta expands MHRA licence to bring analytical testing in-house

    reacta-mhra-licence-analytical-testing Reacta Healthcare has received an extension to its Manufacturer’s [...]

    June 10, 2026
  • Biotech & Pharma Business,Manufacturing & Supply Chain

    Gaelic Laboratories completes first phase of Athlone integration

    Gaelic Laboratories has completed the first phase of the integration [...]

    June 9, 2026
  • Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain

    Sapio Sciences and ZS partner on biopharma laboratory digitalisation

    Sapio Sciences has partnered with consulting and technology firm ZS [...]

    June 9, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Lonza expands DNA-to-IND offering to accelerate biologics development timelines

    Lonza has expanded its integrated DNA-to-IND biologics development offering, introducing [...]

    June 8, 2026
  • Manufacturing & Supply Chain

    Ofichem unifies CDMO and pharmaceutical supply brands under single identity

    Ofichem has consolidated its multiple business units into a single [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Research finds scientists view ELNs as ‘glorified filing cabinets’, driving duplication and shadow AI use

    A new survey by Sapio Sciences has found widespread frustration [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain

    Spore.Bio appoints Michael Miller as VP of scientific and regulatory affairs

    Spore.Bio has appointed Michael Miller as vp of scientific and [...]

    May 5, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    SGD Pharma leads pharma packaging innovation and decarbonisation at Pharmapack Europe 2026

    SGD Pharma, a global producer of pharmaceutical glass primary packaging, [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Lonza to acquire Redberry to expand rapid microbiology testing for pharmaceutical quality control

    Lonza has signed an agreement to acquire Redberry, a French [...]

    May 5, 2026
Previous234Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Polaryx advances Phase 2 trial of PLX-200 in four rare diseases
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Lumen Bioscience gets up to $7M to advance LMN-1001 into Phase 1
    Categories: Advanced Therapies, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development
  • Brainomix to present five ILD studies on quantitative CT at ERS Congress
    Categories: Advanced Therapies, Clinical & Regulatory, Digital & Data, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top